CIK 0001870144 · <br>Emerging growth company
Cardio Diagnostics Holdings, Inc.
Sign in to watch- Ticker
- CDIO
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870925574
- Phone
- 855-226-9991
- Business address
- 311 W. SUPERIOR STREET, SUITE 444, CHICAGO, IL, 60645
- Former names
- Mana Capital Acquisition Corp.
Securities
- CDIO Common stock Nasdaq
- CDIOW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-23 | Dogan Timur Chief Technology Officer | Grant or award · Stock Options (Right to Buy) | +157,750 | $1.26 | $199K | 157,750 |
| 2023-06-23 | Dogan Timur Chief Technology Officer | Grant or award · Stock Options (Right to Buy) | +272,250 | $1.26 | $343K | 272,250 |
| 2023-06-23 | Dogan Meeshanthini Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +272,250 | $1.26 | $343K | 272,250 |
| 2023-06-23 | Dogan Meeshanthini Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +157,570 | $1.26 | $199K | 157,750 |
| 2023-06-23 | Abdullahi Khullani VP of Revenue and Strategy | Grant or award · Stock Options (Right to Buy) | +66,000 | $1.26 | $83K | 66,000 |
| 2023-06-23 | Luqman Elisa V Chief Financial Officer | Grant or award · Stock Options (Right to Buy) | +57,750 | $1.26 | $73K | 57,750 |
| 2023-06-23 | Dogan Timur Chief Technology Officer | Grant or award · Stock Options (Right to Buy) | +156,750 | $1.26 | $198K | 156,750 |
| 2023-06-23 | Philibert Robert Chief Medical Officer | Grant or award · Stock Options (Right to Buy) | +148,500 | $1.26 | $187K | 148,500 |
| 2023-06-23 | Hosseinion Warren Director | Grant or award · Stock Options (Right to Buy) | +123,750 | $1.26 | $156K | 123,750 |
| 2023-06-23 | Dogan Meeshanthini Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +272,250 | $1.26 | $343K | 272,250 |
| 2023-06-19 | Lau Stanley K. Director | Grant or award · Restricted Stock Units | +0 | |||
| 2023-06-19 | Intrater James Director | Grant or award · Restricted Stock Units | +0 | |||
| 2023-06-19 | Sim Brandon Director | Grant or award · Restricted Stock Units | +0 | |||
| 2023-06-19 | Levy Oded Director | Grant or award · Restricted Stock Units | +0 | |||
| 2022-10-25 | Mana Capital LLC 10% owner | Other disposition | −1,565,000 | 0 | ||
| 2022-10-25 | Mana Capital LLC 10% owner | Other disposition · Private Warrant | −2,500,000 | 0 | ||
| 2021-11-30 | Mana Capital LLC 10% owner | Other acquisition | +75,000 | 1,565,000 |
Page 7 of 7 · 137 trades